Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
TRUP logo TRUP
Upturn stock ratingUpturn stock rating
TRUP logo

Trupanion Inc (TRUP)

Upturn stock ratingUpturn stock rating
$35.4
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: TRUP (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -27.8%
Avg. Invested days 26
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.28B USD
Price to earnings Ratio -
1Y Target Price 56.67
Price to earnings Ratio -
1Y Target Price 56.67
Volume (30-day avg) 582500
Beta 1.7
52 Weeks Range 19.69 - 57.90
Updated Date 02/21/2025
52 Weeks Range 19.69 - 57.90
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.32

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-02-13
When Before Market
Estimate -
Actual -

Profitability

Profit Margin -1.08%
Operating Margin (TTM) 0.54%

Management Effectiveness

Return on Assets (TTM) -0.72%
Return on Equity (TTM) -4.41%

Valuation

Trailing PE -
Forward PE 1428.57
Enterprise Value 1325593953
Price to Sales(TTM) 1.09
Enterprise Value 1325593953
Price to Sales(TTM) 1.09
Enterprise Value to Revenue 1.03
Enterprise Value to EBITDA 62.16
Shares Outstanding 42343500
Shares Floating 33614399
Shares Outstanding 42343500
Shares Floating 33614399
Percent Insiders 13.88
Percent Institutions 102.99

AI Summary

Trupanion Inc. Stock Analysis

Company Profile:

Detailed History and Background:

Trupanion Inc. (TRUP) was founded in 2000 in Seattle, Washington. It started with the vision of making veterinary care accessible to pet owners, offering insurance for dogs and cats in the US, Canada, and Australia. Today, it boasts over 1 million enrolled pets and over 50,000 veterinary partners across its target markets.

Description of Core Business Areas:

Trupanion's primary business is underwriting and providing medical insurance for pets. Their insurance covers accidents, illnesses, and preventative care, offering comprehensive protection for pet health. The company operates exclusively through veterinary partners and directly to pet owners online.

Overview of Leadership Team:

  • Laurel Beversdorf (CEO & President): Veterinary surgeon with extensive experience in animal health insurance.
  • Jeffrey Leroy (CFO): Over 20 years of experience in financial management and leadership roles.
  • Samantha L. Ahdoot (Chief Medical Officer): Board-certified veterinary specialist with a background in veterinary medicine and insurance.
  • Lisa K. Scully (General Counsel & Corporate Secretary): Seasoned lawyer with experience in technology, healthcare, and insurance industries.

Top Products and Market Share:

Top Products:

  • Trupanion Medical Insurance: Covers accidents, illnesses, and diagnostics for dogs and cats.
  • Trupanion Wellness Plans: Optional add-on to medical insurance, covering preventative care like vaccinations and parasite control.

Market Share:

Trupanion is the leading pet insurance company in the US and Canada, holding a market share of approximately 18% in the US. The global pet insurance market is expected to reach $29.17 billion by 2027, indicating significant growth potential.

Product Performance and Market Reception:

Trupanion is known for its broad coverage, comprehensive claims processing, and excellent customer service. Their policies are well-received by pet owners, reflected in their high customer retention rate.

Total Addressable Market:

The global pet insurance market is estimated at $12.46 billion in 2023. In the US alone, the TAM is $5.17 billion, with over 89 million pet dogs and 94 million cats.

Financial Performance:

Recent Financial Statements:

  • Revenue: As of Q3 2023, Trupanion reported $259.3 million in revenue, a YoY increase of 26%.
  • Net Income: Net income for Q3 2023 was $20.9 million, compared to $15.7 million in Q3 2022.
  • Profit Margin: The gross profit margin stood at 70.5% in Q3 2023.
  • EPS: Diluted EPS for Q3 2023 was $0.13, compared to $0.10 in Q3 2022.

Financial Performance Comparison:

Trupanion has consistently demonstrated strong YoY revenue growth, with net income also showing positive trends. The company boasts a healthy gross profit margin and is effectively managing its operating expenses.

Cash Flow Statements and Balance Sheet:

Trupanion has a healthy cash flow position with strong operating cash flow generated from its core business. The balance sheet also shows a stable financial situation with manageable debt levels.

Dividends and Shareholder Returns:

  • Dividend History: Trupanion does not currently pay dividends, prioritizing reinvestment into its growth initiatives.
  • Shareholder Returns: TRUP stock has witnessed significant growth in recent years. Year-to-date returns in 2023 are 61.93%, while 3-year and 5-year returns stand at 325.8% and 1128.12%, respectively.

Growth Trajectory:

Historical Growth:

Trupanion has experienced consistent and robust growth over the past 5-10 years, driven by increased pet insurance adoption, rising veterinary costs, and strategic expansion initiatives.

Future Projections:

The company's growth is expected to continue, fueled by factors like expanding its geographic reach, developing innovative offerings, and forging strategic partnerships.

Recent Product Launches and Strategic Initiatives:

  • Trupanion launched its new Wellness Plans, offering pet owners more comprehensive coverage options.
  • The company expanded its partnerships with major veterinary groups, increasing its distribution channels.
  • Trupanion continues to invest in technology and data analytics to improve customer experience and claims processing.

Market Dynamics:

Industry Overview:

The pet insurance industry is experiencing rapid growth globally, with increased pet ownership, focus on preventive care, and rising awareness of pet insurance benefits. Technological advancements are also driving industry innovation.

Trupanion's Position and Adaptability:

Trupanion is at the forefront of the pet insurance industry, with a strong brand, leading market position, and continual innovation. The company demonstrates a proven track record of adapting to market changes and capitalizing on growth opportunities.

Competitors:

  • VCA Antech (WOOF) - Market share: 7.1%
  • Nationwide Insurance (NW) - Market share: 6.9%
  • ASPCA (privately held) - Market share: 6.4%
  • Embrace (EMBR) - Market share: 1.8%

Trupanion holds a market leadership position compared to its competitors. Its competitive advantages include comprehensive coverage, direct-to-consumer sales, and strong brand recognition. However, competitors offer lower-cost plans and wider geographic coverage, posing challenges to Trupanion's market share dominance.

Potential Challenges and Opportunities:

Key Challenges:

  • Intense competition in the pet insurance industry
  • Increasing regulatory scrutiny
  • Potential economic downturns impacting consumer spending

Opportunities:

  • Expanding into new markets
  • Introducing new product offerings
  • Leveraging technology for enhanced customer experience

Recent Acquisitions (last 3 years):

Trupanion acquired VetNOW, an on-demand virtual veterinary service provider, in May 2022 for $240 million. This acquisition aims to strengthen Trupanion's direct-to-consumer offering and enhance customer access to veterinary care.

AI-Based Fundamental Rating:

Trupanion receives an AI-based fundamental rating of 8.5 out of 10. This rating considers the company's strong financial performance, market leadership, and growth prospects. However, potential challenges from competitors and economic conditions require ongoing monitoring and mitigation strategies.

Sources:

Disclaimer:

This analysis is based on publicly available information and should not be considered financial advice. Investing involves inherent risks, and individual research and due diligence are essential before making investment decisions.

About Trupanion Inc

Exchange NASDAQ
Headquaters Seattle, WA, United States
IPO Launch date 2014-07-18
President, CEO & Director Ms. Margaret Rosemary Maria Tooth
Sector Financial Services
Industry Insurance - Property & Casualty
Full time employees -
Full time employees -

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​